Voronoi (310210.KQ) Stock Price

Voronoi Price

CLOSED
118,200.00
​
Market closed

Over the last 6 years Voronoi grew revenue by 71.0% annually, reaching 7.51 B KRW. For Voronoi, the net margin of -568.5% is up versus -16,627.5% a few years ago. The consensus 12-month price target for Voronoi is 326,400.00 KRW, about 176.1% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

Voronoi stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Voronoi business model & stock analysis

Voronoi, Inc. engages in the manufacture of novel kinase inhibitors and target protein degrader drugs. The company is headquartered in Incheon, Incheon. The company went IPO on 2022-06-24. The firm is principally engaged in the technology transfer of new drug candidates prior to electroclinical clinical trials. The firm is principally engaged in the research and development of kinase inhibitor as well as others. In addition, the Company is also engaged in the building and supply of new drug development platforms based on artificial intelligence (AI) and research results.

Frequently asked questions about Voronoi

Analysts currently set an average price target of 326,400.00 KRW for the Voronoi stock (median: 326,400.00 KRW), implying +176.1 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Voronoi stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Voronoi to generate revenue of 5.50 B KRW and earnings per share of -4,602.03 KRW.

Converted at the current exchange rate, the Voronoi share trades at 78.99 EUR (118,200.00 KRW).

The expected revenue of Voronoi is 5.50 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Voronoi is -82.79 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Voronoi is currently -25.68. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Voronoi stock.

The price-to-sales ratio (P/S) of Voronoi is currently 386.62. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Voronoi stock.

The Eulerpool Quality Score for Voronoi is 2/10.

The ISIN of Voronoi is KR7310210000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Voronoi is 310210.KQ. The ticker symbol is used to trade Voronoi shares on the stock exchange.

Fair ValueTerminal
114,654.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website voronoi.io
Country
South Korea
Currency
KRW
Initial public offering
Jun 24, 2022
ISIN
KR7310210000
Cusip
Y93874108
Market capitalization
2.07 T KRWMega Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-25.68
P/Ee 2027
-34.15
P/Se
386.62
EV/EBIT
—
P/B Ratio
19.96
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-30.28 %
Last updated Oct 15, 2026, 1:30 PM

Voronoi Peer Group

Voronoi FIGI

310210:KS · BBG00RYF92H7310210:KQ · BBG014SPCQX7

All fundamentals and in-depth analysis of Voronoi

Our stock analysis for Voronoi stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Voronoi. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.